Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 29;12(1):27.
doi: 10.3390/mi12010027.

Microfluidic Device with an Integrated Freeze-Dried Cell-Free Protein Synthesis System for Small-Volume Biosensing

Affiliations

Microfluidic Device with an Integrated Freeze-Dried Cell-Free Protein Synthesis System for Small-Volume Biosensing

Taishi Tonooka. Micromachines (Basel). .

Abstract

Microfluidic devices enable the precise operation of liquid samples in small volumes. This motivates why microfluidic devices have been applied to point-of-care (PoC) liquid biopsy. Among PoC liquid biopsy studies, some report diagnostic reagents being freeze-dried in such microfluidic devices. This type of PoC microfluidic device has distinct advantages, such as simplicity of the procedures, compared with other PoC devices using liquid-type diagnostic reagents. Despite the attractive characteristic, only diagnostic reagents based on the cloned enzyme donor immunoassay (CEDIA) have been freeze-dried in the microfluidic device. However, development of the PoC device based on the CEDIA method is time-consuming and labor-intensive. Here, we employed a molecule-responsive protein synthesis system as the diagnostic reagent to be freeze-dried in the microfluidic device. Such molecule-responsive protein synthesis has been well investigated in the field of molecular biology. Therefore, using the accumulated information, PoC devices can be efficiently developed. Thus, we developed a microfluidic device with an integrated freeze-dried molecule-responsive protein synthesis system. Using the developed device, we detected two types of bio-functional molecules (i.e., bacterial quorum sensing molecules and mercury ions) by injecting 1 µL of sample solution containing these molecules. We showed that the developed device is applicable for small-volume biosensing.

Keywords: cell-free protein synthesis (CFPS); freeze-dry; microfluidic device; point-of-care (PoC).

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
Fabrication procedures of the microfluidic device integrated with the cell-free protein synthesis (CFPS) system. (a) Image of the whole microfluidic device. (b) Microscopic image of the microchambers in the microfluidic device. (c) Time-lapse microscopic images during the procedures to introduce the CFPS solution in the microchambers. (d) Bright-field image (d1) and fluorescent image (d2) of the freeze-dried CFPS system in the microchambers. The freeze-drying condition was ~10 mTorr, −20 °C, 3 h.
Figure 2
Figure 2
Rehydration of freeze-dried CFPS system in microchambers using an aqueous sample solution. (ac) Microscopic time-lapse images of the microchambers after injecting 1 μL of the aqueous sample solution from the inlet. (d) Microscopic images of the microchambers filled with the rehydrated CFPS solution. The freeze-drying condition was ~10 mTorr, −20 °C, 3 h.
Figure 3
Figure 3
Protein synthesis using freeze-dried CFPS system and freeze-dried DNA. (a) Schematic diagram of the gene circuit demonstrated in (b,c). (b) Time-lapse fluorescent images of the representative microchamber freeze-dried together with the DNA shown in (a). The scale bar is 100 µm. (c) Time-course of the fluorescent intensities in the microchambers with (+DNA) or without DNA (−DNA). SD shows standard deviation (n ≧ 3 each). The freeze-drying condition of the microfluidic device was ~30 mTorr, −80 °C, 6 h.
Figure 4
Figure 4
(a) Schematic diagram of N-acyl-homoserine-lactone (AHL) sensing using AHL-responsive DNA (pAHL-deGFP). (b) Time-course of the fluorescence intensities in the microchambers with the gene circuit shown in (a). The time interval between each image acquisition was 15 min. SD shows standard deviation (n ≧ 3 each). The freeze-drying condition of the microfluidic device was ~30 mTorr, −80 °C, 6 h.
Figure 5
Figure 5
Characterization of mercury sensing DNA (pHg-deGFP). (a) Schematic diagram of mercury sensing using the mercury sensing DNA. (b) Time-course of the fluorescent intensities of the CFPS solution with various pHg-deGFP concentrations. +Hg2+ and −Hg2+ represent the sample with/without 200 nM of Hg2+ respectively. (c) Time-course of the average fluorescent intensities of the CFPS solution with various Hg2+ concentrations. The CFPS solution contained 200 ng/μL of pHg-deGFP. The inset shows the magnified graph around ΔF/F0 = 0. Curves with the dark colors represent average (Mean). Curves with the light colors represent average ± standard deviation (n = 3) (Mean ± SD). The time interval between each data acquisition in (b,c) was 5 min.
Figure 6
Figure 6
Detection of mercury ions in the water sample. (a) Microscopic images of the representative microchambers with 200 nM of Hg2+ (upper row) and 0 nM of Hg2+ (lower row). Bright-field images at the initial state (left end) and time-lapse fluorescence images from 0 to 80 min. The exposure time was 5 s. The time interval between acquiring images was 10 min. The scale bars are 100 µm. (b) Time-course of the average relative fluorescence intensities in the microchambers with water containing 200 nM of Hg2+ (+Hg2+) or 0 nM of Hg2+ (−Hg2+). 200 ng/µL of pHg-deGFP was contained in the CFPS solution when freeze-drying. Curves with the dark colors represent average values (Mean). Curves with the light colors represent average ± standard deviation (n = 4) (Mean ± SD). The freeze-drying condition of the microfluidic device was ~10 mTorr, −20 °C, 3 h.
Figure 7
Figure 7
Detection of mercury ions in a water sample from the Kamo river. Average relative fluorescence intensities in the microchambers with river water containing 50 nM of Hg2+ (+50 nM Hg2+, red bars) and non-treated river water (+0 nM Hg2+, blue bars) after 1.0, 3.5, and 6.5 h. The river water sample with 50 nM of Hg2+ was prepared by dissolving HgCl2 into the river water. The water samples were injected in the microfluidic device at 0 h. Error bars represent standard deviation (n = 4). * p < 0.5, ** p < 0.5, *** p < 0.05 (Welch’s t-test) [25]. The freeze-drying condition of the microfluidic device was ~10 mTorr, −20 °C, 3 h.

Similar articles

Cited by

References

    1. Kulinsky L., Noroozi Z., Madou M. Present technology and future trends in point-of-care microfluidic diagnostics. Methods Mol. Biol. 2013;949:3–23. - PubMed
    1. Barbosa A.I., Reis N.M. A critical insight into the development pipeline of microfluidic immunoassay devices for the sensitive quantitation of protein biomarkers at the point of care. Analyst. 2017;142:858–882. doi: 10.1039/C6AN02445A. - DOI - PubMed
    1. Lazar I.M., Gulakowski N.S., Lazar A.C. Protein and Proteome Measurements with Microfluidic Chips. Anal. Chem. 2020;92:169–182. doi: 10.1021/acs.analchem.9b04711. - DOI - PMC - PubMed
    1. Ng A.H.C., Fobel R., Fobel C., Lamanna J., Rackus D.G., Summers A., Dixon C., Dryden M.D.M., Lam C., Ho M., et al. A digital microfluidic system for serological immunoassays in remote settings. Sci. Transl. Med. 2018;10:eaar6076. doi: 10.1126/scitranslmed.aar6076. - DOI - PubMed
    1. Nishiyama K., Sugiura K., Kaji N., Tokeshi M., Baba Y. Development of a microdevice for facile analysis of theophylline in whole blood by a cloned enzyme donor immunoassay. Lab Chip. 2019;19:233–240. doi: 10.1039/C8LC01105B. - DOI - PubMed

LinkOut - more resources